TWTora Grauers Willadsen

Tora Grauers Willadsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tora Grauers Willadsen has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Volkert Siersma

    Section of General Practice, The Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen K, Denmark

    7 shared publications
  • Niels de Fine Olivarius

    The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark

    5 shared publications
  • Susanne Reventlow

    Section of General Practice and The Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark

    5 shared publications
  • Rasmus Køster-Rasmussen

    Section of General Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark

    4 shared publications
  • Ann Dorrit Guassora

    Centre for General Practice: The Section of General Practice Medicine and The Research Unit for General Practice, Department of Public Health, University of Copenhagen

    3 shared publications
  • Dorte Ejg Jarbøl

    Research Unit of General Practice, Department of Public Health, University of Southern Denmark

    3 shared publications

Latest Publications

  • Open Access

    Methods and baseline results of the Cohort of Health-Related Outcomes in Chronic Illness Care in General Practice in Denmark (CHRONIC-GP)

    by Henrik Hp Larsen, Tora G Willadsen, Anders Prior, Anna B Lyhnebeck, Frans B Waldorff, Anne Holm

    Purpose: The Cohort of Health-Related Outcomes in Chronic Illness Care in General Practice was established using data collected as part of a cluster-randomised trial. This aims to support the trial’s follow-up and enable further examination of the interplay between chronic disease, multimorbidity (MM), polypharmacy (PP) and quality of life (QoL) in a Danish general practice setting. Participants: The cohort comprises 35 977 adult patients from 250 general practices participating in a cluster-randomised trial and had a response rate of 22.4%. Participants were either registered as chronic care patients or had attended an annual chronic disease consultation. They completed a comprehensive questionnaire on self-reported chronic conditions, medication use, QoL, treatment burden and patient-centred care. Additionally, 431 general practitioners (GPs) from the participating practices completed a questionnaire about managing patients with complex MM. Findings to date: Among participants, 51.9% were female, the mean age was 65.6 (SD 12.9) years, 93.1% had education beyond basic schooling, and half were retired. Conditions from more than one organ system-based disease group were reported by 82.2%, and 94.6% used one or more prescription medications. The main challenges reported by the participating GPs in managing patients with complex MM were keeping time and obtaining an overview of the patient’s health status. Future plans: Cohort data will be linked with Danish registries to improve the detection and treatment of chronic conditions and PP in general practice. Registration: The cluster randomised trial (MM600) is registered with ClinicalTrials.gov ID: NCT05676541 .


  • Open Access

    The impact of diabetes mellitus and chronic obstructive pulmonary disease on mortality among people with dementia: a nationwide population-based cohort study

    by Anna Bebe, Tora Grauers Willadsen, Jakob Kragstrup, Anni Brit Sternhagen Nielsen, Anne Møller, Jens Søndergaard, Volkert Siersma, Dagný Rós Nicolaisdóttir, Pernille Hølmkjaer, Frans Boch Waldorff

    People with dementia have higher mortality compared to individuals without dementia. Dementia itself and comorbidity, but also impaired function and self-care, probably all contribute to the high mortality. Dementia is characterized by a high degree of comorbidity and demand for self-care, and so are Diabetes Mellitus (DM) and Chronic Obstructive Pulmonary Disease (COPD). All three diseases can severely impact functioning and quality of life. The aim of this study is to examine the excess mortality associated with DM and COPD in patients with dementia, compared with persons without these diseases, in Danish residents aged ≥ 65 years. The cohort included all individuals aged ≥ 65 years living in Denmark on January 1st, 2009, in total 874,426 individuals. All-cause mortality among persons with dementia, DM, and COPD was compared to persons free of these diseases. We estimated the incidence rate ratio (IRR), with confidence intervals (CI), for all-cause mortality associated with the three diseases separately, and in combination, using Cox regression models. Finally, to understand the consequences when diseases coexist, an interaction effect on mortality was calculated for all combinations of diseases as the IRR for the combination divided by the product of the IRR of the individual diseases. The increase in all-cause mortality was IRR 2.86 (95% CI 2.83–2.89) for dementia, 1.45 (1.44–1.47) for DM, and 2.22 (2.20–2.24) for COPD. For the disease combinations mortality was IRR 3.93 (95% CI 3.83–4.04) for dementia and DM, 5.05 (95% CI 4.92–5.19) for dementia and COPD, and 3.34 (95% CI 3.26–3.41) for DM and COPD. Mortality for the combination of all three diagnoses was 5.66 (95% CI 5.36–5.98). The interaction effect on mortality was < 1, i.e. lower than expected from the total mortality related to the individual diseases, for all possible combinations of the three diseases, and lowest when dementia was involved in the combination. Dementia, DM, and COPD were independently, and in combination, associated with increased mortality. Contrastingly, coexistence seemed less deadly than the diseases on their own, possibly because they being discovered at an earlier stage, still, emphasizing the importance of focusing on shared health factors when treating patients with dementia.


  • Open Access

    Prevalence of multimorbidity during 18 years in Denmark. A nationwide register study

    by Rasmus Køster-Rasmussen, Volkert Siersma, Dagny R. Nicolaisdóttir, Frederikke A. Modin, Asger Waagepetersen, Maarten Rozing, Anne Holm, Susanne Reventlow, Tora G. Willadsen

    Background: The number of patients with multimorbidity challenges healthcare systems worldwide. Objective: To explore the development of multimorbidity prevalence in the Danish population over the course of 18 years. Design: National registers were used to form eighteen cohorts including all persons aged ≥18 years; one cohort for each separate calendar year from 2000 to 2018. Multimorbidity was defined based on ten diagnosis groups (ICD-codes): lung, musculoskeletal, endocrine, mental, cancer, neurological, gastrointestinal, cardiovascular, genitourinary, and sensory organs. At least two diagnoses from different diagnosis groups had to be present to be considered multimorbidity. The diagnoses were from hospital contacts in the Danish health registers. We report both ≥2 and ≥4 multimorbidity. Results: From 2000-2018, the prevalence of multimorbidity increased from 7.1 % to 16.1 % with a relative increase of 126% and 314% for ≥2 and ≥ 4 diagnosis groups, respectively. The oldest age groups had the highest prevalence. In 2018, half of the population aged ≥80 years had multimorbidity. Young women showed the relatively largest prevalence increase of ≥ 4 multimorbidity. In absolute terms, the number of musculoskeletal diagnoses increased the most, whereas genitourinary, endocrinological, and musculoskeletal diagnoses showed the highest relative increase. Conclusions: In Denmark, the prevalence of patients with multimorbidity is increasing, and it has more than doubled from 2000-2018. The observed development in occurrence of multimorbidity over time may serve as relevant input for governments when rethinking the health care.


  • Open Access

    ’Stuck or unstable’ — partnerships between GPs and patients with complex chronic conditions: A qualitative study

    by Mads Aage Toft Kristensen, Mette Bech Risør, Andreas Søndergaard Heltberg, Tora Grauers Willadsen, Ann Dorrit Guassora

    Background: In chronic care, patient–GP collaboration is essential, but might be challenging if patients have complex health problems because of multimorbidity, psychosocial predicaments, and addiction problems. To understand and manage these challenges, it is important to explore how patients and GPs attempt to collaborate, to maintain and achieve an alliance in order to gain good quality of care. Aim: To explore how dyads of GPs and patients, who GPs deem have complex health problems and difficulties following treatment, perceive and manage challenges in their chronic care partnership. Design & setting: This was a qualitative study from Danish general practice in deprived, rural areas. Method: Semi-structured interviews were conducted with 12 dyads of GPs and patients with doctor-assessed complex chronic conditions and difficulties following treatment. The principles of systematic text condensation were used in the analysis. Results: Overall, the patient–GP collaboration could be characterised as either ‘stuck’ or ‘unstable’. In both types, the challenges were identified as pointless consultations, conflicts about lifestyle, resignation, concealment of information, and hopelessness. These challenges could be managed by solving conflicts, adjusting to the patient’s needs, accommodating the challenges in the relationship, and offering continued emotional support even with unsolved medical problems. Conclusion: Care of patients with complex health problems may present several challenges. In this study, patients and GPs experienced the relational dimension as crucial for collaboration. A robust therapeutic alliance, incorporating the patient’s agenda, offers an essential foundation for enhancing care in individuals with complex health problems.

  • Open Access

    Medical practitioners’ experiences and considerations when managing sleep medication for adolescents and young adults

    by Nanna Maria Andersen, Ásthildur Árnadóttir, Tora Grauers Willadsen, Gritt Overbeck

    The prevalence of sleep disorders and use of sleep medication, particularly melatonin, are rising among adolescents and young adults (13-24 years). In Denmark, melatonin is approved for use in children with autism and ADHD up to 18 years of age, with other prescriptions being off-label in these age groups. The perspectives of medical practitioners on prescribing sleep medications to this age group remain largely unexplored. This study aims to investigate the considerations of general practitioners (GPs) and child and adolescent psychiatrists (psychiatrists) when prescribing and deprescribing sleep medications for 13-24-year-olds. We conducted qualitative semi-structured interviews with 10 GPs and six psychiatrists. Data were analyzed using an inductive approach. Psychiatrists typically prescribed melatonin with the expectation that deprescription would occur in general practice. Despite the universal goal of deprescription, it was hindered by various challenges. GPs identified patient motivation and a clear focus on deprescription as facilitative factors and expressed a need for enhanced emphasis on these aspects in general practice. The findings align with existing prescription trends and literature on factors that promote and inhibit deprescription. The study underscores the complexities of deprescribing sleep medications for adolescents and young adults, suggesting the need for expanded guidelines and enhanced continuing education for GPs. The research highlights significant discrepancies among medical practitioners regarding the deprescription process of sleep medications for young individuals, complicated by multiple factors. This underscores the need for better guidelines and further studies.


  • Open Access

    Effectiveness of an adaptive, multifaceted intervention to enhance care for patients with complex multimorbidity in general practice: protocol for a pragmatic cluster randomised controlled trial (the MM600 trial)

    by Anne Holm, Anna Bernhardt Lyhnebeck, Maarten Rozing, Sussi Friis Buhl, Tora Grauers Willadsen, Anders Prior, Ann-Kathrin Lindahl Christiansen, Jette Kristensen, John Sahl Andersen, Frans Boch Waldorff, et al.

    Introduction Patients with complex multimorbidity face a high treatment burden and frequently have low quality of life. General practice is the key organisational setting in terms of offering people with complex multimorbidity integrated, longitudinal, patient-centred care. This protocol describes a pragmatic cluster randomised controlled trial to evaluate the effectiveness of an adaptive, multifaceted intervention in general practice for patients with complex multimorbidity. Methods and analysis In this study, 250 recruited general practices will be randomly assigned 1:1 to either the intervention or control group. The eligible population are adult patients with two or more chronic conditions, at least one contact with secondary care within the last year, taking at least five repeat prescription drugs, living independently, who experience significant problems with their life and health due to their multimorbidity. During 2023 and 2024, intervention practices are financially incentivised to provide an extended consultation based on a patient-centred framework to eligible patients. Control practices continue care as usual. The primary outcome is need-based quality of life. Outcomes will be evaluated using linear and logistic regression models, with clustering considered. The analysis will be performed as intention to treat. In addition, a process evaluation will be carried out and reported elsewhere. Ethics and dissemination The trial will be conducted in compliance with the protocol, the Helsinki Declaration in its most recent form and good clinical practice recommendations, as well as the regulation for informed consent. The study was submitted to the Danish Capital Region Ethical Committee (ref: H-22041229). As defined by Section 2 of the Danish Act on Research Ethics in Research Projects, this project does not constitute a health research project but is considered a quality improvement project that does not require formal ethical approval. All results from the study (whether positive, negative or inconclusive) will be published in peer-reviewed journals. Trial registration number NCT05676541.


  • Open Access

    The effect of disease onset chronology on mortality among patients with multimorbidity: A Danish nationwide register study

    by Tora G Willadsen, Volkert Siersma, Dagny R Nicolaisdóttir, Rasmus Køster-Rasmussen, Susanne Reventlow, Maarten Rozing

    Background: Multimorbidity is associated with increased mortality. Certain combinations of diseases are known to be more lethal than others, but the limited knowledge of how the chronology in which diseases develop impacts mortality may impair the development of effective clinical interventions for patients with multimorbidity. Objective: To explore if in multimorbidity the chronology of disease onset is associated with mortality. Design: A prospective nationwide cohort study, including 3,986,209 people aged ≥18 years on 1 January 2000, was performed. We included ten diagnosis groups: lung, musculoskeletal, endocrine, mental, cancer, neurological, gastrointestinal, cardiovascular, kidney, and sensory organs. We defined multimorbidity as the presence of at least two diagnoses from two diagnosis groups (out of ten). To determine mortality, logistic regression models were used to calculate odds ratios (OR) and ratio of ORs (RORs). Results: For most combinations of multimorbidity, the chronology of disease onset does not change mortality. However, when multimorbidity included mental health diagnoses, mortality was in general higher if the mental health diagnosis appeared first. If multimorbidity included heart and sensory diagnoses, mortality was higher if these developed second. For the majority of multimorbidity combinations, there was excess mortality if multimorbidity was diagnosed simultaneously, rather than consecutively, for example, heart and kidney (3.58 ROR; CI 2.39–5.36), or mental health and musculoskeletal diagnoses (2.38 ROR; CI 1.70–3.32). Conclusions: Overall, in multimorbidity, the chronology in which diseases develop is not associated with mortality, with few exceptions. For almost all combinations of multimorbidity, diagnoses act synergistically in relation to mortality if diagnosed simultaneously.


  • Open Access

    Symptom burden in multimorbidity: a population-based combined questionnaire and registry study from Denmark

    by Tora Grauers Willadsen, Volkert Siersma, Dagny Ros Nicolaisdottir, Dorte Jarbol, Ann Dorrit Guassora, Susanne Reventlow, Rasmus Køster-Rasmussen

    Objective: Patients with multimorbidity may carry a large symptom burden. Symptoms are often what drive patients to seek healthcare and they also assist doctors with diagnosis. We examined whether symptom burden is additive in people with multimorbidity compared with people with a single morbidity.Design: This is a longitudinal cohort study drawing on questionnaire and Danish national registry data. Multimorbidity was defined as having diagnoses from at least two out of ten morbidity groups. Associations between morbidity groups and symptom burden were estimated with multivariable models.Participants: In 2012, 47 452 participants from the Danish Symptom Cohort answered a questionnaire about symptoms (36 symptoms in total), including whether symptoms were affecting their daily activities (impairment score) and their worries about present symptoms (worry score) (the highest score among the 36 symptoms on a 0–4 scale).Main outcome measure: The primary outcome was symptom burden.Results: Participants without morbidity reported 4.77 symptoms (out of 36 possible). Participants with one, two or three morbidities reported more symptoms than patients without morbidity (0.95 (CI 0.86 to 1.03), 1.87 (CI 1.73 to 2.01) and 2.89 (CI 2.66 to 3.12), respectively). Furthermore, they reported a higher impairment score (0.36 (0.32 to 0.39), 0.65 (0.60 to 0.70) and 1.06 (0.98 to 1.14)) and a higher worry score (0.34 (0.31 to 0.37), 0.62 (0.57 to 0.66) and 1.02 (0.94 to 1.10)) than participants without morbidity. In 45 possible combinations of multimorbidity (participants with two morbidities), interaction effects were additive in 37, 41 and 36 combinations for the number of symptoms, impairment score and worry score, respectively.Conclusion: Participants without morbidity reported a substantial number of symptoms. Having a single morbidity or multimorbidity resulted in approximately one extra symptom for each extra morbidity. In most combinations of multimorbidity, symptom burden was additive.


  • Open Access

    Prioritizing social identities: Patients’ perspective on living with multimorbidity

    by Camilla Drivsholm Sand, Keren Rahbek, Tora G Willadsen, Alexandra R Jønsson

    Objective: This article explores experiences of people with multimorbidity, and attempts to advance understandings of the complexity of living with multimorbidity outside the medical encounter in a social identity theoretical framework. Method: This is a qualitative study using individual semi-structured interviews among nine persons living with multimorbidity. The interviews are analysed inductively according to thematic content analysis. Results: The emerging themes are: 1) Impact on daily life, 2) Professional life and 3) Capacity for handling multimorbidity. People with multimorbidity experience physical limitations and psychological distress, which limits their ability to maintain social relations and affiliation to the labour market. Accordingly, they are challenged in their ability to retain a sense of normal everyday life, which is mediated by their capacity for handling multimorbidity. Discussion: Multimorbidity may compromise various social identities. The complexity of living with multimorbidity is increased by an aspiration to maintain valued social identities in order to preserve a coherent sense of self and a normal everyday life. This study suggests an increased focus on individual priorities and values outside the medical encounter, and argues in favour of recognizing the conflicts that people experience as they try to balance multimorbidity with other important aspects of their daily lives.


  • Open Access

    The association between clusters of chronic conditions and psychological well-being in younger and older people—A cross-sectional, population-based study from the Lolland-Falster Health Study, Denmark

    by Lars Hermann Tang, Lau Caspar Thygesen, Tora Grauers Willadsen, Randi Jepsen, Karen la Cour, Anne Frølich, Anne Møller, Lars Bo Jørgensen, Søren T Skou

    Aim: To investigate the association between clusters of conditions and psychological well-being across age groups. Method: This cross-sectional study used data collected in the Danish population-based Lolland-Falster Health Study. We included adults over the age of 18 years. Self-reported chronic conditions were divided into 10 groups of conditions. The primary outcome was psychological well-being (the WHO-5 Well-Being Index). Factor analysis constructed the clusters of conditions, and regression analysis investigated the association between clusters and psychological well-being. Results: Of 10,781 participants, 31.4% were between 18 and 49 years, 35.7% were between 50 and 64 years and 32.9% were above ≥65 years. 35.2% had conditions represented in 1 and 32.9% in at least 2 of 10 condition groups. Across age groups, living with one or more chronic conditions was associated with poorer psychological well-being. Two chronic condition patterns were identified; one comprised cardiovascular, endocrine, kidney, musculoskeletal and cancer conditions, the second mental, lung, neurological, gastrointestinal and sensory conditions. Both patterns were associated with poorer psychological well-being (Pattern 1: −4.5 (95% CI: −5.3 to −3.7), Pattern 2: −9.1 (95% CI −13.8 to −8.2). For pattern 2, participants ≥65 years had poorer psychological well-being compared to younger (−12.6 (95% CI −14.2 to −11.0) vs −6.6 (95% CI: −7.8 to −5.4) for 18–49 years and −8.7 (95% CI: −10.1 to −7.3) for 50–64 years, interaction: p ≤ 0.001) Conclusion: Living with one or more chronic conditions is associated with poorer psychological well-being. Findings point toward a greater focus on supporting psychological well-being in older adults with both mental and somatic conditions.